(July 1, 2024, 2:32 PM EDT) -- WASHINGTON, D.C. — Two former Acclarent Inc. executives convicted of distributing and misbranding medical devices sold in interstate commerce who say the U.S. Food and Drug Administration’s “intended use” regulations violate their constitutional rights argue in a July 1 reply brief in the U.S. Supreme Court that the case is “an ideal vehicle to review enormously important and contested constitutional questions.”...